Shelley Force Aldred, Ph.D.

CEO at Rondo Therapeutics

Speaker

Shelley Force Aldred, a scientist and serial entrepreneur, is CEO and Co-founder of Rondo Therapeutics. Previously, Dr. Force Aldred was a member of TeneoBio’s founding team where she led preclinical development for the company’s CD3 T-cell engager platform which achieved notable success through partnerships and an acquisition by Amgen. Early in her career, Dr. Force Aldred earned a Ph.D. in Genetics from Stanford and developed a passion for starting companies when she co-founded SwitchGear Genomics which later sold to Active Motif.